Boardroom Alpha
Research library
Activism · May 7, 2026

Viasat Agrees to Add Two Carronade-Backed Directors

Viasat Inc. (VSAT) has entered into a cooperation agreement with Carronade Capital Management, expanding its board from eight to ten directors. This agreement comes as Viasat trails the S&P 500 by 6 points on a five-year CAGR basis. Carronade, holding a 3.8%…

Viasat Inc. (VSAT) has entered into a cooperation agreement with Carronade Capital Management, expanding its board from eight to ten directors. This agreement comes as Viasat trails the S&P 500 by 6 points on a five-year CAGR basis. Carronade, holding a 3.8% stake, secures two independent board seats.

VSAT 5-Year Price · CARRONADE CAPITAL MANAGEMENT, LP ownership

VSAT 5-year price chart

1Y CAGR
+622.9%vs S&P +31.4% (+591.5pp)
3Y CAGR
+21.6%vs S&P +21.2% (+0.4pp)
5Y CAGR
+6.1%vs S&P +11.9% (-5.8pp)
Source: Boardroom Alpha · 13-F holdings via SEC filings

Viasat Inc. has agreed to appoint two independent directors, Shekar Ayyar and Jinhy Yoon, to its board, expanding it from eight to ten members. The Strategic Review Committee will also include these new directors, who will enjoy equal compensation and responsibilities as other non-management directors. Olshan Frome Wolosky represented Carronade, while Latham & Watkins advised Viasat.

Carronade Capital Management, which initiated its stake in Viasat with a 0.35% ownership in March 2025, has progressively increased its position to 3.8%. The stock has surged by 656.2% since Carronade’s initial filing, climbing from $8.9 to its current close of $67.3. This recovery follows a significant 89% drawdown from its peak in November 2021.

The agreement includes a standstill provision effective until the 2027 Annual Meeting nomination deadline, restricting Carronade from engaging in certain shareholder actions without board approval. Carronade commits to supporting board-nominated directors and agrees to limit its ownership transactions during this period. The Investor Group will also receive reimbursement for up to $150,000 in documented expenses related to the agreement.

Cooperation Agreement Summary
Activist
CARRONADE CAPITAL MANAGEMENT, LP
Emerging · 2 campaigns · 1 proxy fight · 1 cooperation agreement · 6 seats placed
Board Seat Shekar Ayyar and Jinhy Yoon join the board
Standstill Effective until 2027 Annual Meeting nomination deadline
Committee Assignment Appointed to Strategic Review Committee
Voting Support Carronade supports board-nominated directors
Reimbursement Up to $150,000 for documented expenses
ShareXLinkedIn

Published May 7, 2026 · last updated May 7, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer